Zhejiang Operating Income from 2010 to 2025

002099 Stock   4.95  0.12  2.37%   
Zhejiang Hisoar's Operating Income is decreasing over the years with stable fluctuation. Overall, Operating Income is projected to go to about -181.8 M this year. Operating Income is earnings before interest and taxes (EBIT), representing the amount of profit Zhejiang Hisoar Pharmaceutical generates from its operations. View All Fundamentals
 
Operating Income  
First Reported
2006-09-30
Previous Quarter
68.3 M
Current Value
-247 K
Quarterly Volatility
91.8 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Zhejiang Hisoar financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Zhejiang Hisoar's main balance sheet or income statement drivers, such as Interest Expense of 45.6 M, Net Income Applicable To Common Shares of 201.2 M or Selling General Administrative of 161.1 M, as well as many indicators such as . Zhejiang financial statements analysis is a perfect complement when working with Zhejiang Hisoar Valuation or Volatility modules.
  
This module can also supplement various Zhejiang Hisoar Technical models . Check out the analysis of Zhejiang Hisoar Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Zhejiang Stock

Zhejiang Hisoar financial ratios help investors to determine whether Zhejiang Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Zhejiang with respect to the benefits of owning Zhejiang Hisoar security.